    James Tananbaum | Foresite Capital LP | ZoomInfo.com





James B. Tananbaum, M.D. - Executive Profile




























Education
Blog
About









 Investors
 Companies





 

EXECUTIVE PROFILE
James B. Tananbaum, M.D.
Share this profile Tweet 



JAMES B. TANANBAUM, M.D. BACKGROUND / BIOGRAPHY




Jim is a Managing Director of Prospect Venture Partners. Jim co-founded Prospect Venture Partners II and III, as dedicated life science funds with over $1 billion in capital under management. During the last two decades, Jim has helped found and/or finance drug discovery companies focused on producing innovative therapies including GelTex Pharmaceuticals (NASDAQ:GENZ), Theravance Pharmaceuticals (NASDAQ:THRX),Infinity Pharmaceuticals (NASDAQ:INFI), Vitae Pharmaceuticals, and Amira Pharmaceuticals. He also has co-lead investments in a number of specialty pharmaceutical companies including Jazz Pharmaceuticals, RoxRo Pharmaceuticals, and Vanda Pharmaceuticals (NASDAQ:VNDA). Previously, as a partner at Sierra Ventures he led investments in Amerigroup (NASDAQ:AMGP), Healtheon (NASDAQ:WBMD), Intensiva HealthCare Corporation (NASDAQ: CSEL) and NovaMed EyeCare Management (NASDAQ:NOVA). Jim founded GelTex which was ultimately purchased for $1.6B by Genzyme (NASDAQ: GENZ) while finishing school and, in 1997, founded Theravance (NASDAQ: THRX) where as CEO for its first three years the company grew to over 200 employees. From 1991 to 1993, Jim was a senior product manager at Merck & Co., Inc. (NYSE:MRK) where he was part of the team responsible for repositioning Prilosec. Dr. Tananbaum received his undergraduate degree and B.S.E.E. from Yale University, an MD and MBA from Harvard.






INVESTOR

Prospect Venture Partners 




TITLE
Managing Director




INVESTOR ADDRESS
435 Tasso StreetPalo Alto, CA 94301United States








LEARN MORE ABOUT JAMES B. TANANBAUM, M.D.
If interested in more biographies and information for over 500,000 executives, and investors, visit CB Insights.
















 Education Blog About Privacy Policy Terms of Service Sitemap
© CB Information Services, 2010









James B. Tananbaum, Board Dir., Novavax Inc.














A publisher of Business Information since 1983   
  





 


   

Search Business Search Executive 
  Advanced Search 




  

Sign In  |  Hints 









Profile of James Tananbaum 





 


James Tananbaum

 

Board Dir. - Novavax Inc.

 


James Tananbaum Email :
Please login 

 

Company Name : 
Novavax Inc. 

 

Company Website : 
www.novavax.com 

 

Company Address : 
9920 Belward Campus Dr., Rockville, MD,United States, 


 


James Tananbaum Profile :
Board Dir. - Novavax Inc. 

 


James Tananbaum Biography :


Jim is a Managing Director of Prospect Venture Partners. Jim co-founded Prospect Venture Partners II and III, a dedicated life science fund with over $1 billion in capital under management. During the last decade, Jim has helped found and lead financing for numerous biotechnology, pharmaceutical and healthcare service companies. Most recently, Dr. Tananbaum helped found and/or led investments for Prospect in Infinity Pharmaceuticals (NASDAQ: DPII), Jazz Pharmaceuticals, Novavax (NASDAQ:NVAX), Pathworks, Comphealth, Nanosys, Vanda Pharmaceuticals (NASDAQ: VNDA) and Vitae Pharmaceuticals. Previously, as a partner at Sierra Ventures he led investments in Amerigroup (NASDAQ:AMGP), Healtheon (NASDAQ:WBMD), Intensiva HealthCare Corporation (NASDAQ: CSEL) and NovaMed EyeCare Management (NASDAQ:NOVA). From 1991 to 1993, Jim was a senior product manager at Merck & Company, Inc where he was part of the team responsible for repositioning Prilosec.Jim was also the founder of two successful biotechnology companies - GelTex which he founded in 1991 while finishing school and was ultimately purchased for $1.6 B by Genzyme (NASDAQ: GENZ) and Theravance (NASDAQ: THRX), founded in 1997 where as CEO he started and grew the company to over 200 employees and raised more than $300 million. Jim is a member of the Young Presidents' Organization and Chapter Chair Golden Gate Chapter and a member of the Harvard/MIT Health Sciences and Technology Visiting Committee, and on the board of the DeYoung Museum of Fine Arts. Dr. Tananbaum received his undergraduate degree and B.S.E.E. from Yale University, an MD and MBA from Harvard. 

 


James Tananbaum Colleagues :





Name 
Title 
Email 


Gary Evans 
Lead Board Dir. 
Please login 


Raymond Hage 
Sr. VP - Commercial Operations 
Please login 


John Marsh 
Board Dir. 
Please login 


Rahul Singhvi 
Board Dir., Pres., CEO 
Please login 


Gale Smith 
VP - Vaccine Development 
Please login 













            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory    





 

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.





HST 35th Anniversary - Profile of James B. Tananbaum, MD 1989




























James B. Tananbaum, MD 1989
-Managing Director, Prospect Venture Partners
-Co-founder Prospect Venture Partners II and III
Career Highlights:Dr. Tananbaum received his undergraduate degree and BSEE from Yale University, his MBA from Harvard Business School and his MD from Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology.

Dr. Tananbaum's career has been in the private sector where he has helped found and lead financings for numerous biotechnology, pharmaceutical and healthcare service companies, including Jazz Pharmaceuticals, PatientCare, Predicant, Comphealth, Nanosys, Vanda Pharmaceuticals and Vitae Pharmaceuticals. Prospect Venture Partners II and III are dedicated life science funds with over $1 billion in capital under management.  

Previously, as a partner at Sierra Ventures, he led investments in numerous companies, and from 1991-1993, Dr. Tananbaum was a senior product manager at Merck & Company.  

Dr. Tananbaum founded two successful biotechnology companies -- GelTex which he founded in 1991 while fininshing his MD degree and which was ultimately purchased by Genzyme for $1.6 billion; and Theravanace, founded in 1997, which just announced a landmark partnership with Glaxco.










James B Tananbaum - San Francisco, CA | Intelius



























Sign In



We found James B Tananbaum in San Francisco, CA


James B Tananbaum

                                                                           Intelius found that James B Tananbaum  is  a male between 50 and 60 years old from San Francisco, CA.  We have connected them to
                15 addresses,
                8 phones,
                and 3 relatives or associates.
         





Also Known As

James Bruce Tananbaum


Get Report Now

Age

James B Tananbaum is in his 50s

James Has Lived In

San Francisco, CA
Palo Alto, CA
South San Francisco, CA

James's Relatives

Marcia Shonfeld
Dana Tananbaum
Edwin Shonfeld







James B Tananbaum



Zodiac SignTaurus



GenderMale



Professional Status
Board Member at Critical Therapeutics



Get Report Now










Want to know more about James? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about James, or use our people search engine to find others.
Get Background Check on James B Tananbaum
Get a Criminal Check on James B Tananbaum
Get a Public Record Report on James B Tananbaum
Get a People Search Report on James B Tananbaum


James B Tananbaum's Contact Information
Known Cities Lived In
Find out where James B Tananbaum has lived as well as James B Tananbaum's phone numbers and email addresses.




James B Tananbaum Has Lived in 3 States
California Address for James B Tananbaum


3899 J****** S* 

San Francisco, CA


Has Lived In

San Francisco, CA
Palo Alto, CA


Get Full Address Report










Phone Numbers Associated with James B Tananbaum

(415) ***-**** - San Francisco, CA 
(415) ***-**** - San Francisco, CA 
(707) ***-**** - Saint Helena, CA 


Get Full Phone Report



Email Addresses Associated with James B Tananbaum

j********m@***.com
j********m@***.com
j********m@***.com


Get Email Report




James B Tananbaum's Professional Information
Information regarding James B Tananbaum's professional history.  Find out previous places James B Tananbaum has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


James B Tananbaum Has Worked at 8 Places
Company: Critical Therapeutics
               Title: Board Member
Company: Infinity Pharmaceuticals Inc
               Title: Prospect Venture Partners
James B Tananbaum's Experience
Title: Board Member
               Company: Critical Therapeutics
Job Details
               Critical Therapeutics, Inc. is developing and commercializing innovative products for respiratory, inflammatory and critical care diseases. The Company owns worldwide rights to two FDA-approved drugs for the prevention and chronic treatment of asthma in patients 12 years of age and older: twice-daily ZYFLO CR(TM) (zileuton) extended-release tablets and ZYFLO(R) (zileuton tablets). Critical Therapeutics is working to develop products for acute asthma attacks that lead patients to the emergency room and other urgent care settings. The Company also is developing therapies directed toward the body's inflammatory response.
Title: Prospect Venture Partners
               Company: Infinity Pharmaceuticals Inc
Job Details
               Infinity is an innovative drug discovery and development company seeking to discover, develop and deliver to patients best-in-class medicines for difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs focused on the inhibition of the Hedgehog pathway, heat shock protein 90 and phosphoinositide-3-kinase are evidence of its innovative approach to drug discovery and development.
Additional Professional Information on James B Tananbaum

 See James B Tananbaum's LinkedIn Profile



James B Tananbaum's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for James B Tananbaum


James B Tananbaum's known Social Networks And Potential Email Matches

Find all of James B Tananbaum's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
James Tananbaum
Username Matches

                  JamesTananbaum
                  TananbaumJames
                  James.Tananbaum
                  Tananbaum.James
                  James_Tananbaum
                  Tananbaum_James
                  James-Tananbaum
                  Tananbaum-James
                  JTananbaum
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
J Tananbaum







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.













James B. Tananbaum M.D., MBA: Executive Profile & Biography - Bloomberg









































  





















































































July 28, 2017 8:22 PM ET
Capital Markets

Company Overview of Foresite Capital Management, LLC



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
James B. Tananbaum M.D., MBAChief Executive Officer, Founder, and Managing Director, Foresite Capital Management, LLCAgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 18 different industries.See Board Relationships54--
Background

		Dr. James B. Tananbaum, also known as Jim, M.D., MBA, is Chief Executive Officer, Founder and Managing Director at Foresite Capital Management, L.L.C. Dr. Tananbaum founded Foresite Capital Management, L.L.C in 2011 and also has been its Chief Executive Officer and Managing Director since 2011. He has been the chief architect of Foresite's organization and investment strategy and has played a significant role in numerous Foresite companies. Dr. Tananbaum is a Co-Founder ... of Cogentus Pharmaceuticals, Inc. He has also co-lead investments in a number of specialty pharmaceutical companies including Jazz Pharmaceuticals, RoxRo Pharmaceuticals and Vanda Pharmaceuticals. He serves as an Affliate Partner of Prospect Venture Partners; Prospect Venture Partners II, L.P. and Prospect Venture Partners III, L.P. Dr. Tananbaum founded Innoviva, Inc. (a/k/a: Theravance Inc.) in 1997 and served as its Chief Executive Officer until 2000. He served as the President at Innoviva, Inc. (a/k/a: Theravance Inc.) From 1994 to 1997, Dr. Tananbaum served as a Partner at Sierra Ventures and played a key role in the Healthcare Technology Group and led its healthcare service and health care information enterprises effort. During the last two decades, Dr. Tananbaum has helped found and finance drug discovery companies focused on producing innovative therapies including , Theravance Pharmaceuticals, Vitae Pharmaceuticals, Amira Pharmaceuticals and Novavax. From 1991 to 1993, Dr. Tananbaum served as Senior Product Manager at Merck & Co., Inc., where he was part of the team responsible for repositioning Prilosec. In 1991, he co-founded GelTex Pharmaceuticals while finishing school. Dr. Tananbaum founded and served as start up Chief Executive Officer at Infinity Pharmaceuticals, Biospect and Concurrent Pharmaceuticals and also serves on the Boards of these companies. He co-founded Pathwork Diagnostics, Inc. in 2002 and served as its Chairman. He is the Founding Chairman of Orange Coast Managed Care Services. He has been a Director of Jazz Pharmaceuticals plc since January 18, 2012. Dr. Tananbaum serves on the Board of Directors of NovaMed EyeCare and Patient Care, Inc. He served as a Director of Intensiva Healthcare Corporation since December 1994. Dr. Tananbaum is a Founding Member of the Harvard/MIT Health Sciences and Technology Advisory Group, the Vice Chairman of the Harvard Medical School Cell Biology and Pathology Advisory Council; a Member of the Board of Directors at the California Healthcare Institute; on the Board of the DeYoung Museum of Fine Arts. Dr. Tananbaum has been a Director of Shaklee Global Group, Inc. since 2013. He serves as a Director at Mindstrong, Inc. He serves as Director of Sequenta, Inc. He serves as a Director of Tarsa Therapeutics, Inc. since March 16, 2012. He served as a Director of Aimmune Therapeutics, Inc. (formerly Allergen Research Corporation) since March, 2015. He served as a Director of Vitae Pharmaceuticals, Inc. until September 1, 2013. Dr. Tananbaum served as a Director at Infinity Pharmaceuticals, Inc. from September 2006 to May 15, 2012, Vanda Pharmaceuticals, Inc. from 2004 to June 2007, Amira Pharmaceuticals Inc. since November 28, 2005, Critical Therapeutics Inc. from June 21, 2005 to June 22, 2007, Jazz Pharmaceuticals Public Limited Company from 2003 to May 24, 2011 and Novavax, Inc. from April 26, 2006 to October 2009. He served as a Director of Theravance Inc., Cogentus Pharmaceuticals, Inc., GelTex Pharmaceuticals, Inc. until 1997. He served as a Director of ROXRO PHARMA, Inc. and NovaMed Inc. Dr. Tananbaum served on the Board of Directors of Pathwork Diagnositcs, Inc., Jazz Pharmaceuticals, Inc., and LookSmart, Ltd. He has served on the Advisory Boards of the Harvard-MIT HST program and Yale School of Engineering. He previously served on the boards of numerous private and public pharmaceutical and biotech companies as well as Fine Arts Museums of SFOver the last 20 years, Dr. Tananbaum has led investments in 21 successful companies, producing several multibillion and multi hundred million dollar outcomes. Heis an industry leader with 25 years of healthcare entrepreneurial and investing experience. He focuses on strategic, operational and financial opportunities to build franchise healthcare businesses. During 25 years, he has founded and/or helped grow healthcare franchises in all segments of the healthcare economy. He is a three-time Forbes Midas List honoree. Dr. Tananbaum holds an M.D. in 1989 from Harvard Medical School, an M.B.A. in 1991 from Harvard Business School and a B.S.E.E. and B.S. from Yale University in 1985.Read Full Background




Corporate Headquarters
600 Montgomery StreetSan Francisco, California 94111United StatesPhone: 415-877-4887Fax: 415-567-0091
Board Members Memberships
DirectorCalifornia Life Sciences AssociationDirectorPatient Care, Inc.DirectorTarsa Therapeutics, Inc.DirectorSequenta, Inc.DirectorMindstrong, Inc.2013-PresentDirectorShaklee Global Group, Inc.
Education
MBA Harvard Business SchoolBS Yale UniversityBSE Yale UniversityMD Harvard Medical School
Other Affiliations
Prospect Venture PartnersSierra VenturesInnoviva, Inc.LookSmart Group, Inc.NovaMed Inc.GelTex Pharmaceuticals, Inc.Merck & Co., Inc.Novavax, Inc.Intensiva HealthCare CorporationCalifornia Life Sciences AssociationPatient Care, Inc.Critical Therapeutics Inc.Harvard Business SchoolInfinity Pharmaceuticals, Inc.Vitae Pharmaceuticals, Inc.Yale UniversityPathwork Diagnostics, Inc.Prospect Venture Partners II, L.P.Shaklee Global Group, Inc.Harvard Medical SchoolJazz Pharmaceuticals Public Limited CompanyProspect Venture Partners III, L.P.Vanda Pharmaceuticals Inc.Amira Pharmaceuticals, Inc.ROXRO PHARMA, Inc.Cogentus Pharmaceuticals, Inc.Tarsa Therapeutics, Inc.Sequenta, Inc.Aimmune Therapeutics, Inc.Mindstrong, Inc.


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Foresite Capital Management, LLC, please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close




























James Tananbaum, Foresite Capital Management LLC: Profile & Biography - Bloomberg


































































  




































Feedback





James "Jim" Tananbaum

CEO/Mng Dir/Founder,
Foresite Capital Management LLC






Career History




Co-Founder
Innoviva Inc, 1/2016-PRESENT


CEO/Mng Dir/Founder
Foresite Capital Management LLC, 2011-PRESENT


Co-Founder
Prospect Venture Partners, 5/2010-PRESENT


Co-Founder
Discovery Partners Intl Inc, 2001-PRESENT


Founder
Advanced Medicine Corp, 12/2000-PRESENT


Co-Founder
Young Presidents Org, PRESENT


Officer
Presidents Organization, PRESENT


Co-Founder
Theravance Inc, PRESENT


Co-Founder
Geltex Pharmaceuticals Inc, PRESENT


Co-Founder
Theravance Inc, 2000-1/2016


Managing Director/Co-Founder
Prospect Venture Partners, 12/2000-5/2010


CEO/Co-Founder
Theravance Inc, 1997-2000


CEO/Founder
Advanced Medicine Corp, 1996-12/2000


Partner
Sierra Ventures Ltd, 1993-1997


Founder
Foresite Capital Management LLC, 2011-UNKNOWN


CEO/Co-Founder
Theravance Inc, 2000-UNKNOWN


Co-Founder
Geltex Pharmaceuticals Inc, 1991-UNKNOWN


Founding Partner
Prospect Venture Ptnrs II LP, FORMER


Founding Partner
Prospect Venture Ptnrs III LP, FORMER


Show More









Website:
www.foresitecapital.com






Corporate Information
Address:

101 California Street
Suite 4100
San Francisco, CA 94111
United States


Phone:
1-415-877-4887


Fax:
1-415-567-0091


Web url:
www.foresitecapital.com











From The Web












Personal Information



Education



Yale University
Bachelor's Degree, Electrical Engineering


Yale University
Bachelor's Degree


Harvard Business School
MBA


Harvard Medical School
MD


Massachusetts Institute of Technology
Master's Degree


Show More








Memberships



Board Memberships




Pathworks Inc


Board Member, PRESENT




Cogentus Pharmaceuticals Inc


Board Member, PRESENT




Roxro Pharma Inc


Board Member, PRESENT




Lapis Therapeutics Inc


Board Member, PRESENT




Patient Care Inc


Board Member, PRESENT




Vitae Therapeutics Inc


Board Member, PRESENT




Pathwork Diagnostics Inc


Board Member, PRESENT




Sequenta Inc


Board Member, 7/2013-PRESENT




Tarsa Therapeutics Inc


Board Member, 3/2012-PRESENT




Vitae Pharmaceuticals Inc


Board Member, UNKNOWN-9/2013




Infinity Pharmaceuticals Inc


Board Member, 9/2006-5/2012




Foresite Capital Management LLC


Trustee, 7/2010-2011




Jazz Pharmaceuticals Inc


Board Member, 2003-5/2011




Novavax Inc


Board Member, 4/2006-9/2009




Vanda Pharmaceuticals Inc


Board Member, 2004-6/2007




Critical Therapeutics Inc


Board Member, UNKNOWN-6/2007




Discovery Partners Intl Inc


Board Member, 2001-9/2006




Looksmart Ltd


Board Member, 5/2000-6/2002




Novamed Eyecare Inc


Board Member, 1/1997-8/2000




Intensiva Healthcare Corp


Board Member, 12/1994-12/1998




Amira Pharmaceuticals Inc


Board Member, FORMER




Amerigroup Corp


Board Member, FORMER




Allergen Research Corp


Board Member, 3/2015-UNKNOWN




Shaklee Global Group Inc


Board Member, 2013-UNKNOWN



Show More





Other Memberships




Harvard Medical Schl Advisory Council


Vice Chairman




Harvard MIT Health Sciences & Tech Advisory Group


Member




California Healthcare Inst


Board Member




World Economic Forum


Member




Yale University Council 


Member



Show More








Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data


































JAMES B  TANANBAUM - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











JAMES B  TANANBAUM
Check out list of companies and businesses related to JAMES B  TANANBAUM. Find out JAMES B  TANANBAUM address and contact details. View other people related to JAMES B  TANANBAUM - coworkers, colleagues, companions, etc.
Address:   

C/O PROSPECT VENTURE PARTNERS 435 TASSO STREET, SUITE 200 PALO ALTO 94301 CA




Companies related to JAMES B  TANANBAUM
CIKCompany NamePositionCompany Address0001000694NOVAVAX INCDirector 20 FIRSTFIELD ROAD  GAITHERSBURG 208780001113148INFINITY PHARMACEUTICALS, INC.Director 784 MEMORIAL DRIVE  CAMBRIDGE 021390001145404CORNERSTONE THERAPEUTICS INCDirector 1255 CRESCENT GREEN DRIVE SUITE 250 CARY 275180001178879AMICUS THERAPEUTICS INC1 CEDAR BROOK DRIVE  CRANBURY 085120001232524Jazz Pharmaceuticals plcDirector FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN 40001276591HANSEN MEDICAL INC800 EAST MIDDLEFIELD ROAD  MOUNTAIN VIEW 940430001298521Trubion Pharmaceuticals, Inc2401 4TH AVENUE SUITE 1050 SEATTLE 981210001347178Vanda Pharmaceuticals Inc.Director 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON 20037




JAMES B  TANANBAUM on the Web
Persons related to JAMES B  TANANBAUM - NOVAVAX INCNamePositionCitySUSAN B  BAYHDirector WASHINGTONGAIL  BOUDREAUXDirector CAMBRIDGECadila Pharmaceuticals LtdBHAT, AHMEDABAD  GUJARATCadila Pharmaceuticals Ltd10% Owner BHAT, AHMEDABAD GUJARATJEFFREY WAYNE  CHURCHMALVERNJEFFREY WAYNE  CHURCHVP, CFO, Treasurer & Corp. Sec ROCKVILLERICHARD  DOUGLASDirector CAMBRIDGERICHARD  DOUGLASDirector ROCKVILLERICHARD  DOUGLASDirector GAITHERSBURGFREDERICK W  DRISCOLLVP, CFO & Treasurer ROCKVILLEStanley C  ErckPresident and CEO GAITHERSBURGStanley C  ErckDirector ROCKVILLEStanley C  ErckPresident and CEO ROCKVILLEStanley C  ErckCEO and President GAITHERSBURGGARY C  EVANSDirector DALLASGARY C  EVANSDirector ROCKVILLEGARY C  EVANSDirector GAITHERSBURGGARY C  EVANSDirector FLOWER MOUNDGARY C  EVANSDirector MALVERNGARY C  EVANSDirector ROCKVILLEGRAY C  EVANSDirector IRVINGGRAY C  EVANSDirector DALLASDENNIS W  GENGEVP, Treasurer,CFO COLUMBIADENNIS W  GENGEVP, Treasurer,CFO MALVERNGregory M  GlennPresident, R&D GAITHERSBURGGregory M  GlennChief Scientific Officer ROCKVILLEGregory M  GlennROCKVILLEGregory M  GlennSVP, Research and Development GAITHERSBURGJOHN M  GREGORYBRISTOLRaymond Joseph  HageSVP, Commercial Operations WEST CHESTERRaymond Joseph  HageSr. VP, COO MALVERNRaymond Joseph  HageSVP, Commercial Operations ROCKVILLERaymond Joseph  HageSr. VP. Commercial Operations ROCKVILLETimothy Jon  HahnSVP, Manufacturing ROCKVILLETimothy Jon  HahnSVP, Manufacturing GAITHERSBURGPatricia  HallChief Accounting Officer MALVERNPenny  HeatonChief Medical Officer ROCKVILLEPenny  HeatonVP & Chief Medical Officer ROCKVILLEJohn A  Herrmann IIISVP, General Counsel GAITHERSBURGThomas Scott  JohnstonVice President, Strategy ROCKVILLEMITCHELL J  KELLYDirector NEW YORKMITCHELL J  KELLYDirector NEW YORKKING PHARMACEUTICALS INC10% Owner BRISTOLEvdoxia E  KopsidasSr.Dir.Fin.,Prin.Acctg.Officer ROCKVILLEJOHN A  LAMBERTDirector ROCKVILLEJ MICHAEL MD  LAZARUSDirector WELLESLEY HILLSJ MICHAEL MD  LAZARUSDirector MALVERNFORD R  LYNCHSr. VP Marketing and Sales COLUMBIAJOHN O  MARSH JRDirector WINCHESTERJOHN O  MARSH JRDirector MALVERNJOHN O  MARSH JRDirector ROCKVILLEJOHN O  MARSH JRDirector ROCKVILLEJOHN O  MARSH JRDirector GAITHERSBURGMICHAEL A  MCMANUS JRDirector BRONXVILLEMICHAEL A  MCMANUS JRDirector ROCKVILLEMICHAEL A  MCMANUS JRDirector GAITHERSBURGMICHAEL A  MCMANUS JRDirector BRONXVILLEMICHAEL A  MCMANUS JRDirector MALVERNMICHAEL A  MCMANUS JRDirector ROCKVILLERajiv I.  ModiDirector BHAT, AHMEDABAD    GUJARATRajiv I.  ModiDirector BHAT, AHMEDABAD GUJARATRajiv I.  ModiDirector BHAT, AHMEDABAD GUJARAT,Thomas P  MonathMALVERNThomas P  MonathDirector ROCKVILLEThomas P  MonathDirector ROCKVILLEDENIS M  ODONNELLDirector WINCHESTERDENIS M  ODONNELLDirector MALVERNDENIS M  ODONNELLDirector ROCKVILLEBARCLAY A  PHILLIPSSVP, Chief Financial Officer CARLSBADBARCLAY A  PHILLIPSROCKVILLEBARCLAY A  PHILLIPSSVP, Chief Financial Officer GAITHERSBURGJim  RobinsonROCKVILLEJim  RobinsonVP, Tech. & Quality Operations ROCKVILLEJim  RobinsonVP of Tech. & Qual. Operations ROCKVILLEJim  RobinsonVP, Technical & Quality Ops. ROCKVILLESatellite Overseas (Holdings) LtdISLE OF MANNELSON M  SIMSPresident/CEO COLUMBIANELSON M  SIMSPresident/CEO MALVERNRahul  SinghviPresident, CEO CHALFONTRahul  SinghviPresident, CEO MALVERNRahul  SinghviPresident, CEO ROCKVILLERahul  SinghviPresident, CEO ROCKVILLESJ STRATEGIC INVESTMENTS LLC10% Owner BRISTOLLen F  StiglianoVP, CFO, Treasurer ROCKVILLELen F  StiglianoVP, CFO and Treasurer ROCKVILLEJAMES B  TANANBAUMDirector PALO ALTOJAMES B  TANANBAUMDirector PALO ALTOMark Owens  ThorntonROCKVILLEJohn  TrizzinoSVP, Commercial Operations ROCKVILLEJohn  TrizzinoSVP, Commercial Operations GAITHERSBURGRONLAD H  WALKERDirector TUCSONRussell P  WilsonSVP, Business Development GAITHERSBURGRussell P  WilsonSVP, Business Development ROCKVILLERussell P  WilsonSVP, Business Development GAITHERSBURGD CRAIG  WRIGHTChief Scientific Officer COLUMBIAJAMES F  YOUNGDirector GAITHERSBURGJAMES F  YOUNGDirector ROCKVILLEJAMES F  YOUNGDirector GAITHERSBURGPersons related to JAMES B  TANANBAUM - INFINITY PHARMACEUTICALS, INC.NamePositionCityJULIAN  ADAMSPresident of R&D CAMBRIDGEPerkins  AdeleneCambridgeEvnin  AnthonyCambridgeMartin  BablerDirector SAN CARLOSMartin  BablerDirector CAMBRIDGEALEXANDER E  BARKASPALO ALTOJose  BaselgaDirector CAMBRIDGECo  BeaconST. HELIER JERSEY CHANNEL ISL.Co  Beacon10% Owner ST. HELIER JERSEY CHANNEL ISL.Co  Beacon10% Owner JERSEY CHANNEL ISLANDSJeffrey  BerkowitzDirector BERNWilliam C  Bertrand JRGeneral Counsel GAITHERSBURGBIOTECHNOLOGY VALUE FUND II LPBIOTECHNOLOGY VALUE FUND L PBiotechnology Value Trading Fund OS LPGRAND CAYMANLAWRENCE E  BLOCHPresident SAN DIEGOLAWRENCE E  BLOCHEVP, CFO & CBO CAMBRIDGELAWRENCE E  BLOCHEVP, CFO & CBO CAMBRIDGEThomas Joseph  BurkeAssistant Treasurer CAMBRIDGEBVF INC/ILBVF PARTNERS L P/IL10% Owner BVF Partners OS Ltd.GRAND CAYMANTAYLOR  CROUCHChief Operating Officer SAN DIEGOTAYLOR  CROUCHPresident & COO SAN DIEGOD Ronald  DanielDirector NEW YORKCOLIN  DOLLERYDirector SAN DIEGOLander  EricCambridgeANTHONY B  EVNINDirector NEW YORKANTHONY B  EVNINDirector CAMBRIDGEANTHONY B  EVNINDirector NEW YORKGwen A.  FyfeDirector SUNNYVALEGwen A.  FyfeDirector CAMBRIDGEGwen A.  FyfeDirector CAMBRIDGEFyfe  GwenCambridgeJoshua  HamermeshVP, Business & Corporate Dev CAMBRIDGEDaniel  HarveyVice President SAN DIEGOHARRY F  HIXSON JRDirector SAN DIEGOHARRY F  HIXSON JRDirector CAMBRIDGESteven H  HoltzmanDirector CAMBRIDGESmith  IanCambridgeAdams  JulianCambridgeSUJAY  KANGOChief Commercial Officer BRIDGEWATERMichael  KauffmanDirector CAMBRIDGECRAIG  KUSSMANChief Financial Officer SAN DIEGOCRAIG  KUSSMANChief Financial Officer SAN DIEGOJeffery  KutokChief Scientific Officer CAMBRIDGEWinston K.C.  LamGeneral Counsel CAMBRIDGEMARK N  LAMPERTSAN FRANCISCOERIC S  LANDERDirector BOSTON,ERIC S  LANDERDirector CAMBRIDGEERIC S  LANDERDirector CAMBRIDGEPatrick Pak-Tin  LeeDirector LONDON,  UNITED KINGDOMPatrick Pak-Tin  LeeDirector CAMBRIDGEARNOLD J  LEVINEDirector PRINCETONARNOLD J  LEVINEDirector CAMBRIDGEALAN  LEWISDirector SAN DIEGOJOHN  LILLIGChief Technology Officer SAN DIEGOJOHN  LILLIGChief Technology Officer SAN DIEGOChristopher M  LindblomPrincipal Accounting Officer CAMBRIDGEChristopher M  LindblomSee Remarks CAMBRIDGEDOUGLAS A  LIVINGSTONSVP Chemistry SAN DIEGOThomas J. Jr.  LynchDirector CAMBRIDGEBabler  MartinCambridgeVenuti  MichaelCambridgeFranklin  MossDirector CAMBRIDGEFranklin  MossDirector CAMBRIDGERICHARD  NEALEVice President SAN DIEGORICHARD  NEALEVice President SAN DIEGOSelby  NormanCambridgeVito J.  PalombellaChief Scientific Officer CAMBRIDGELee  PatrickCambridgeSantabarbara  PedroCambridgeAdelene Q  PerkinsChief Executive Officer CAMBRIDGERICCARDO  PIGLIUCCIChief Executive Officer SAN DIEGORICCARDO  PIGLIUCCIChairman & CEO SAN DIEGOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT MANAGEMENT CO LLCPALO ALTOPROSPECT VENTURE PARTNERS II LPPALO ALTOPROSPECT VENTURE PARTNERS LPPALO ALTOGerald E  QuirkSee Remarks CAMBRIDGEURS  REGENASSVice President SAN DIEGOURS  REGENASSVice President SAN DIEGORosebay Medical Co L.P.10% Owner OKLAHOMA CITYHERM  ROSENMANDirector SAN DIEGOHERM  ROSENMANDirector CAMBRIDGEDavid  RothChief Medical Officer CAMBRIDGEPedro  SantabarbaraChief Medical Officer CAMBRIDGEVICKI L  SATODirector CAMBRIDGEDAVID  SCHNELLPALO ALTONORMAN C  SELBYDirector LEXINGTON,NORMAN C  SELBYDirector CAMBRIDGENORMAN C  SELBYDirector CAMBRIDGENORMAN C  SELBYDirector CAMBRIDGEIAN F  SMITHDirector CAMBRIDGEIAN F  SMITHDirector CAMBRIDGEIAN F  SMITHDirector CAMBRIDGEHoltzman  SteveCambridgeJAMES B  TANANBAUMDirector PALO ALTOJAMES B  TANANBAUMDirector CAMBRIDGESeth A  TaskerGeneral Counsel CAMBRIDGELynch  ThomasCambridgeJeffrey K  TongVP, Cor. & Product Development CAMBRIDGEWinselow S. Jr.  TuckerVice President, Marketing CAMBRIDGEMICHAEL C  VENUTIDirector SAN DIEGOMICHAEL C  VENUTIDirector CAMBRIDGEPalombella  VitoCambridgeJOHN PETER  WALKERDirector SAN DIEGOPersons related to JAMES B  TANANBAUM - CORNERSTONE THERAPEUTICS INCNamePositionCityAdvanced Technology Ventures VI, L.P.WALTHAMAdvanced Technology Ventures VI, L.P.WALTHAMAdvanced Technology Ventures VI, L.P.WALTHAMAdvanced Technology Ventures VII(B), L.P.WALTHAMAdvanced Technology Ventures VII(B), L.P.WALTHAMAdvanced Technology Ventures VII(B), L.P.WALTHAMAdvanced Technology Ventures VII(C), L.P.WALTHAMAdvanced Technology Ventures VII(C), L.P.WALTHAMAdvanced Technology Ventures VII(C), L.P.WALTHAMADVANCED TECHNOLOGY VENTURES VII LPWALTHAMADVANCED TECHNOLOGY VENTURES VII LP10% Owner WALTHAMERIC  AGUIARCAMBRIDGEROBERTS  ALANCARYPOWELL  ANDREWCARYFAILLA  ANTONCARYATV Alliance 2003, L.P.WALTHAMATV Alliance 2003, L.P.WALTHAMATV Alliance Associates, L.L.C.WALTHAMATV Associates VI, L.L.C.WALTHAMATV Associates VI, L.L.C.WALTHAMATV Associates VII, L.L.C.WALTHAMATV Associates VII, L.L.C.WALTHAMATV Entrepreneurs VI, L.P.WALTHAMATV Entrepreneurs VI, L.P.WALTHAMATV Entrepreneurs VI, L.P.WALTHAMATV Entrepreneurs VII, L.P.WALTHAMATV Entrepreneurs VII, L.P.WALTHAMATV Entrepreneurs VII, L.P.WALTHAMChenyqua Michele  BaldwinVice President Finance CARYCarolina Pharmaceuticals Holdings, Ltd.HAMILTONCarolina Pharmaceuticals Ltd.THE VALLEYJAMES H  CAVANAUGHPRINCETONAlessandro  ChiesiPARMAAlessandro  ChiesiDirector PARMAFarmaceutici SpA  Chiesi10% Owner PARMAMaria Paola  ChiesiPARMAChiesi U.S. CorpPARMACODEANNE  CHRISTOPHERCARYCHRISTOPHER GEORGE  CODEANNECARYCHRISTOPHER GEORGE  CODEANNEDirector CARYCraig A  CollardPresident and CEO CARYCraig A  CollardChief Executive Officer CARYCornerstone Biopharma Holdings, Ltd.10% Owner CARYCOLLARD  CRAIGCARYWILLIAM  CROUSEPRINCETONBrian  DicksonChief Medical Officer CARYBrian  DicksonChief Medical Officer CARYIra  DuartePrincipal Accounting Officer CARYIra  DuartePrincipal Accounting Officer CARYRICHARD W  DUGANDirector LEXINGTONMichael David  EnrightDirector CARYMichael David  EnrightCARYGeorge Arthur  EsgroVice President Sales CARYLUKE  EVNIN BOSTONLUKE  EVNINBOSTONAnton Giorgio  FaillaPARMAAnton Giorgio  FaillaDirector PARMAFrederick  FinneganLEXINGTONFrederick  FinneganSVP of Sales and Marketing LEXINGTONJoshua B  FranklinVP, Strategy & Bus. Dev. CARYANSBERT  GADICKEBOSTONANSBERT  GADICKE BOSTONNICHOLAS  GALAKATOSDirector BOSTONNICHOLAS  GALAKATOSDirector BOSTONJean  GeorgeDirector LEXINGTONJean  GeorgeDirector WALTHAMJean  GeorgeDirector WALTHAMJean  GeorgeDirector WALTHAMJames A  HarperDirector CARYJames A  HarperDirector CARYHEALTHCARE PARTNERS  VI LPPRINCETONHEALTHCARE VENTURES VI LP10% Owner PRINCETONMichael Thomas  HeffernanDirector CARYMichael Thomas  HeffernanDirector CARYDana Charles  HiltSVP of Clinical Develop. & CMO LEXINGTONHARPER  JAMESCARYJOHNSON & JOHNSON10% Owner NEW BRUNSWICKJOHNSON & JOHNSON DEVELOPMENT CORP ET ALNEW BRUNSWICKThomas Patrick  KellyCFO & SVP Finance & Corp. Dev, LEXINGTONMCBEAN  KENNETHCARYSHAWVER  LAURACARYAUGUSTINE  LAWLORCAMBRIDGEJOHN W  LITTLECHILDCAMBRIDGESteven Michael  LutzExecutive Vice President CARYSteven Michael  LutzExecutive Vice President CARYAndreas  MaetzelVP, Clinical and Regulatory CARYAndreas  MaetzelVP, Clinical and Regulatory CARYVECCHIA  MARCOCARYKenneth  McBeanPresident CARYKenneth  McBeanPresident CARYALASTAIR STUART  MCEWANDirector CARYALASTAIR STUART  MCEWANCFO and Treasurer CARYMedImmune Ventures, Inc.10% Owner GAITHERSBURGENRIGHT  MICHAELCARYHEFFERNAN  MICHAELCARYCHRISTOPHER  MIRAELLICAMBRIDGECHRISTOPHER  MIRAELLIPRINCETONCHRISTOPHER  MIRAELLIDirector CAMBRIDGEVincent T.  MorgusEVP, Finance and CFO CARYMPM ASSET MANAGEMENT II LLCBOSTONMPM ASSET MANAGEMENT II LLCBOSTONMPM ASSET MANAGEMENT II LPBOSTONMPM ASSET MANAGEMENT II LPBOSTONMPM ASSET MANAGEMENT INVESTORS 2001 LLCBOSTONMPM ASSET MANAGEMENT INVESTORS 2001 LLCBOSTONMPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLCBOSTONMPM BIOVENTURES II GMBH & CO PARALLEL BETEILIGUNGS KGBOSTONMPM BIOVENTURES II GMBH & CO PARALLEL BETEILIGUNGS KGBOSTONMPM BIOVENTURES II LPBOSTONMPM BIOVENTURES II LPBOSTONMPM BIOVENTURES II QP LP10% Owner BOSTONMPM BIOVENTURES II QP LP BOSTONMPM BIOVENTURES III GMBH & COBOSTONMPM BIOVENTURES III GP LPBOSTONMPM BIOVENTURES III LLCBOSTONMPM BIOVENTURES III LPBOSTONMPM BIOVENTURES III QP LP10% Owner BOSTONWalter  NewmanChief Scientific Officer/VP RD LEXINGTONWalter  NewmanCSO/SVP Research & Development LEXINGTONTrevor  PhillipsFormer President & CEO LEXINGTONAndrew Kenneth William  PowellEVP, General Counsel CARYDavid  PriceChief Financial Officer CARYDavid  PriceChief Financial Officer CARYSTEPHAN  ROBERTCARYAlan  RobertsVP, Scientific Affairs CARYAlan  RobertsVP, Scientific Affairs CARYPAUL D  RUBINPresident and CEO LEXINGTONLaura  ShawverDirector CARYLaura  ShawverDirector CARYMICHAEL  STEINMETZBOSTONMICHAEL  STEINMETZ BOSTONRobert  StephanPARMARobert  StephanDirector PARMAJAMES B  TANANBAUMPALO ALTOJAMES B  TANANBAUMDirector PALO ALTOFRANK E  THOMASLEXINGTONFRANK E  THOMASPresident & CEO LEXINGTONScott B  TownsendGENERAL COUNSEL and SVP LEGAL LEXINGTONScott B  TownsendGENERAL COUNSEL and EVP LEGAL CARYScott B  TownsendGENERAL COUNSEL and EVP LEGAL CARYMarco  VecchiaDirector PARMAMORGUS  VINCENTCARYCHRISTOPHER T PHD  WALSHDirector LEXINGTONHowland Shaw  WarrenDirector LEXINGTONHAROLD R  WERNERPRINCETONKURT  WHEELERBOSTONKURT  WHEELER BOSTONJeffrey E  YoungFORMER VP FINANCE & CAO LEXINGTONRobert H  ZeigerDirector LEXINGTONM Cory  ZwerlingDirector CARLISLEPersons related to JAMES B  TANANBAUM - AMICUS THERAPEUTICS INCNamePositionCityBarkas  AlexanderCranburyKurt J.  AndrewsSVP, Human Resources CRANBURYWilliam D  Baird IIIChief Financial Officer CRANBURYMark  BaldryVP Global Marketing CRANBURYJOHN V  BALENWESTPORTSOL J  BARERDirector WARRENSOL J  BARERDirector CRANBURYSOL J  BARERDirector SUMMITALEXANDER E  BARKASDirector PALO ALTOM JAMES  BARRETTBALTIMOREM JAMES  BARRETTDirector TIMONIUMPETER J  BARRIS10% Owner BALTIMOREPETER J  BARRIS10% Owner TIMONIUMJay  BarthChief Medical Officer CRANBURYFOREST  BASKETTBALTIMOREFOREST  BASKETTTIMONIUMStephen M  BlochDirector WESTPORTStephen M  BlochDirector WESTPORTStephen M  BlochDirector WESTPORTPol F  BoudesChief Medical Officer CRANBURYPol F  BoudesChief Medical Officer CRANBURYCampbell  BradleyCranburyCampbell  BradleyCranburyDouglas A  BranchCRANBURYBradley L  CampbellChief Operating Officer CRANBURYBradley L  CampbellChief Operating Officer CRANBURYCANAAN EQUITY III ENTREPRENEURS LLCWESTPORTCANAAN EQUITY III LPWESTPORTCanaan Equity Partners III LLC10% Owner WESTPORTJeff  CastelliSVP, Program Management CRANBURYCHL Medical Partners II, L.P.10% Owner STAMFORDCHL Medical Partners II Side Fund, L.P.10% Owner STAMFORDWheeler  CraigCranburyJohn F  CrowleyChairman & CEO CRANBURYJohn F  CrowleyChairman & CEO CRANBURYQuimi  DaphneCranburyAllsop  DavidSVP International CRANBURYLockhart  DavidCranburyLockhart  DavidCranburyKAMRA  DEEPAKWESTPORTJames E  DentzerChief Financial Officer CRANBURYJames E  DentzerChief Financial Officer CRANBURYEnrique  DiloneSVP, Technical Operations CRANBURYEnrique  DiloneVP, Technical Operations CRANBURYHung  DoChief Science Officer CRANBURYHayden  DonaldCranburyHayden, Jr.  DonaldCranburyDipal  DoshiSVP Strategy & Bus Dev CRANBURYRYAN D  DRANTBALTIMORERYAN D  DRANTTIMONIUMJOSEPH  EDELMANJOSEPH  EDELMANNEW YORKJOSEPH  EDELMANNEW YORKDilone  EnriqueCranburyROBERT  ESSNERDirector MADISONROBERT  ESSNERDirector CRANBURYFHM IV LP10% Owner SEATTLEFHM IV LP10% Owner SEATTLEFHM V, LLCSEATTLEFHM V, LPSEATTLEFRAZIER AFFILIATES IV LPFRAZIER AFFILIATES IV LPSEATTLEFRAZIER HEALTHCARE IV LPSEATTLEFRAZIER HEALTHCARE IV LPFrazier Healthcare V, LPSEATTLEGarden State Life Sciences Venture Fund L P10% Owner PHILADELPHIAGilmore  GeoffreyCranburyJayne  GershkowitzSVP, Chief Patient Advocate CRANBURYGeoffrey  GilmoreSVP & General Counsel CRANBURYPLC  GLAXOSMITHKLINE10% Owner BRENTFORD MIDDLESEXPLC  GLAXOSMITHKLINE10% Owner BRENTFORD MIDDLESEX,Sblendorio  GlenCranburySblendorio  GlennCranburySblendorio  GlennCranburyJeremy  GreenSAN FRANCISCOL STEPHEN  GREENWESTPORTDONALD J  HAYDEN JRDirector PRINCETONDONALD J  HAYDEN JRDirector CRANBURYDONALD J  HAYDEN JRDirector CRANBURYRUSSELL C  HIRSCHPALO ALTORUSSELL C  HIRSCHPALO ALTOBarrett  JamesCranburyBarrett  JamesCranburyTopper  JamesCranburyTopper  JamesCranburyGerskowitz  JayneCranburyCastelli  JeffreyCranburyCastelli  JeffreyCranburyWinterbottom  JoanCranburyCrowley  JohnCranburyCrowley  JohnCranburyMcAdam M  JohnVP, Finance & Accounting CRANBURYKirk  JohnCranburyKirk  JohnCranburyValenzano  KenCranburyValenzano  KenCranburyPeist  KennethCranburyJohn  KirkVP, Regulatory Affairs CRANBURYJohn  KirkVP, Regulatory Affairs CRANBURYKRISHNA KITTU  KOLLURIBALTIMOREKRISHNA KITTU  KOLLURITIMONIUMGREGORY  KOPCHINSKYWESTPORTC RICHARD  KRAMLICH10% Owner BALTIMOREC RICHARD  KRAMLICH10% Owner TIMONIUMGregory P  LicholaiVP, Medical Affairs CRANBURYCHARLES M  LINEHANBALTIMOREDavid J  LockhartChief Scientific Officer CRANBURYDavid J  LockhartChief Scientific Officer CRANBURYTED W  LOVEDirector SUNNYVALETED W  LOVEDirector CRANBURYKarin  LudwigCRANBURYPeter M  MacalusoVP & Corporate Counsel CRANBURYMcGlynn  MargaretCranburyMcGlynn  MargaretCranburyPatterson  MatthewCranburyMARGARET G  MCGLYNNDirector WHITEHOUSE STATIONMARGARET G  MCGLYNNDirector CRANBURYMARGARET G  MCGLYNNDirector CRANBURYRaab  MichaelCranburyRaab  MichaelCranburyRaab  MichaelCranburySinai School of Medicine of New York University  MountNEW YORKNEA 11 GP, LLCBALTIMORENEA 11 GP, LLCTIMONIUMNEA PARTNERS 11 LPBALTIMORENEA PARTNERS 11 LPTIMONIUMP SHERRILL  NEFFDirector PHILADELPHIAP SHERRILL  NEFFDirector PHILADELPHIANEW ENTERPRISE ASSOCIATES 11 LPBALTIMORENEW ENTERPRISE ASSOCIATES 11 LP10% Owner TIMONIUMCHARLES W  NEWHALL III10% Owner BALTIMORECHARLES W  NEWHALL III10% Owner TIMONIUMNeff  PCranburyDavid  PallingSr VP, Technical Operations CRANBURYMatthew R  PattersonActing CEO & President CRANBURYKenneth  PeistVP, Legal & IP CRANBURYKenneth  PeistVP, Legal & IP CRANBURYPERCEPTIVE ADVISORS LLC10% Owner WASHINGTONPERCEPTIVE ADVISORS LLC10% Owner NEW YORKPERCEPTIVE LIFE SCIENCES MASTER FUND LTDWASHINGTONMARK W  PERRY10% Owner BALTIMOREMARK W  PERRY10% Owner TIMONIUMBoudes  PolCranburyBoudes  PolCranburyPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT VENTURE PARTNERS II LP10% Owner PALO ALTOPROSPECT VENTURE PARTNERS II LPPALO ALTOQUAKER BIO VENTURES LP10% Owner PHILADELPHIADaphne  QuimiSVP, Finance CRANBURYDaphne  QuimiVP Finance and Controller CRANBURYMICHAEL  RAABDirector BALTIMOREMICHAEL  RAABBALTIMOREMICHAEL  RAABDirector BALTIMOREMICHAEL  RAABDirector CRANBURYMICHAEL  RAABDirector CRANBURYRedmile Group, LLC10% Owner SAN FRANCISCOEssner  RobertCranburyWinkler  RobertCranburyEllen  RosenbergGeneral Counsel & Corp. Secy CRANBURYSETH  RUDNICKWESTPORTGUY M  RUSSOWESTPORTSchaeffer  SCranburySCOTT D  SANDELLBALTIMORESCOTT D  SANDELLTIMONIUMGLENN  SBLENDORIODirector NEW YORKGLENN  SBLENDORIODirector CRANBURYGLENN  SBLENDORIODirector CRANBURYOrlov S Nicole  SchaefferSVP, HR & Leadership Devt CRANBURYDAVID  SCHNELLPALO ALTODAVID  SCHNELLPALO ALTOAndrew  ShenkerVP, Clinical Research CRANBURYMark  SimonCRANBURYBarer  SolCranburyBarer  SolCranburyJAMES B  TANANBAUMPALO ALTOJAMES B  TANANBAUMPALO ALTOLove  TedCranburyLove  TedCranburyJames N  TopperDirector PALO ALTOJames N  TopperDirector PALO ALTOJames N  TopperDirector PALO ALTOJames N  TopperDirector PALO ALTOJames N  TopperDirector MENLO PARKEUGENE A  TRAINOR IIIBALTIMOREKen  ValenzanoSVP, Pharmacology & Biology CRANBURYKen  ValenzanoVP, Pharmacology & Biology CRANBURYGregory M  WeinhoffDirector STAMFORDGregory M  WeinhoffDirector STAMFORDCRAIG A  WHEELERDirector EMERYVILLEBaird,  William IIICranburyRobert E  WinklerVP, Clin Research & Operations CRANBURYRobert E  WinklerVP, Clin Research & Operations CRANBURYJoan  WinterbottomSVP, Human Resources CRANBURYERIC A  YOUNGWESTPORTJulie  YuVP Clinical Ops & Data Mgmt CRANBURYPersons related to JAMES B  TANANBAUM - Jazz Pharmaceuticals plcNamePositionCitySebulsky  AlanChicagoAlexander E  AlbertNEW YORKE Alexander  AlbertDirector NEW YORKPAUL L  BERNSDirector MIDDLETONPAUL L  BERNSDirector MIDDLETONPAUL L  BERNSDirector PALO ALTOPAUL L  BERNSDirector DUBLIN 2PAUL L  BERNSDirector DUBLIN 4Cressey  BrianChicagoBRIDGER CAPITAL LLCNEW YORKBRIDGER CAPITAL LLCNEW YORKBRIDGER MANAGEMENT LLC10% Owner NEW YORKBRIDGER MANAGEMENT LLC10% Owner NEW YORKCozadd  BrucePalo AltoCozzad  BrucePalo AltoCressey  BryanChicagoMICHAEL M  CALBERTMENLO PARKGamble  CarolPalo AltoADAM  CLAMMERMENLO PARKSAMUEL D  COLELLADirector MENLO PARKJoan  ColliganPALO ALTOJoan  ColliganPrincipal Accounting Officer PALO ALTORussell J.  CoxEVP & COO PALO ALTORussell J.  CoxEVP & Chief Commercial Officer DUBLIN 2Russell J.  CoxEVP & Chief Operating Officer DUBLIN 4Russell J.  CoxEVP & Chief Commercial Officer DUBLINBRUCE C  COZADDChairman & CEO MENLO PARKBRUCE C  COZADDChairman and CEO DUBLIN 2BRUCE C  COZADDChairman and CEO DUBLIN 4BRUCE C  COZADDChairman and CEO DUBLIN 4BRUCE C  COZADDChairman & CEO DUBLIN4BRUCE C  COZADDChairman and CEO PALO ALTOBRUCE C  COZADDChairman and CEO PALO ALTOBRYAN C  CRESSEYDirector CHICAGOBRYAN C  CRESSEYDirector CHICAGOBRYAN C  CRESSEYDirector CHICAGOBRYAN C  CRESSEYDirector CHICAGOBRYAN C  CRESSEYDirector CHICAGOBRYAN C  CRESSEYDirector CHICAGOBRYAN C  CRESSEYDirector CHICAGOMichael A.  DesJardinSVP, Product Development PALO ALTOAlbert  E.Menlo ParkMark G.  EllerSVP, Research & Clinical Dev. PALO ALTOPATRICK G  ENRIGHTDirector BURLINGAMEPATRICK G  ENRIGHTDirector MENLO PARKPATRICK G  ENRIGHTDirector MENLO PARKPATRICK G  ENRIGHTDirector MENLO PARKKATHRYN E  FALBERGSVP and CFO PALO ALTOKATHRYN E  FALBERGEVP and CFO DUBLIN 2KATHRYN E  FALBERGEVP and CFO DUBLIN 4TODD A  FISHERLONDONTODD A  FISHERLONDONTODD A  FISHERLONDONMatthew K  FustEVP, Chief Financial Officer PALO ALTOCarol A  GambleSVP, GC and Secretary PALO ALTOCarol A  GambleSVP, GC and Secretary PALO ALTOCarol A  GambleSVP and General Counsel DUBLIN 2Jacques  GaraialdeLONDONJacques  GaraialdeLONDONJacques  GaraialdeLONDONPERRY  GOLKINNEW YORKReinhard  GorenflosLONDONReinhard  GorenflosLONDONReinhard  GorenflosLONDONPeter  GrayDirector DUBLIN 4JAMES H  GREENE JRMENLO PARKSuzanne Sawochka  HooperEVP & General Counsel DUBLIN 2Suzanne Sawochka  HooperEVP and General Counsel DUBLIN 4Suzanne Sawochka  HooperEVP & General Counsel DUBLIN4JOHANNES P  HUTHLONDONJOHANNES P  HUTHLONDONJOHANNES P  HUTHLONDONPatel  JaiminDirector MENLO PARKTananbaum  JamesPalo AltoMomtazee  JamesMenlo ParkWilliam J  JanetschekNEW YORKWissel  JannePalo AltoColligan  JoanPalo AltoFintan  KeeganDUBLIN 2Fintan  KeeganEVP, Technical Operations DUBLIN 4Fintan  KeeganEVP, Technical Operations DUBLIN 4O'Keefe  KennethChicagoKKR Asset Management LLCNEW YORKKKR Associates Millennium L.P.NEW YORKKKR Associates Millennium L.P.NEW YORKKKR & Co. L.P.NEW YORKKKR & Co. L.P.NEW YORKKKR & Co. LLCNEW YORKKKR FINANCIAL ADVISORS LLCSAN FRANCISCOKKR FINANCIAL HOLDINGS III, LLC SAN FRANCISCOKKR Financial Holdings LLCSAN FRANCISCOKKR FINANCIAL LLCSAN FRANCISCOKKR Fund Holdings GP LtdNEW YORKKKR Fund Holdings GP LtdNEW YORKKKR Fund Holdings L.P.10% Owner NEW YORKKKR Fund Holdings L.P.10% Owner NEW YORKKKR Group Holdings L.P.10% Owner NEW YORKKKR Group Holdings L.P.NEW YORKKKR Group LtdNEW YORKKKR Group LtdNEW YORKKKR III GP LLCNEW YORKKKR III GP LLCNEW YORKKKR JP III LLC10% Owner NEW YORKKKR JP III LLC10% Owner NEW YORKKKR JP LLC NEW YORKKKR JP LLCNEW YORKKKR Management Holdings CorpNEW YORKKKR Management Holdings L.P.NEW YORKKKR Management LLCNEW YORKKKR Management LLCNEW YORKKKR Millennium Fund L.P.NEW YORKKKR Millennium Fund L.P.NEW YORKKKR Millennium GP LLCNEW YORKKKR Millennium GP LLCNEW YORKKKR Partners III, L.P.NEW YORKKKR Partners III, L.P.NEW YORKKohlberg Kravis Roberts & Co.NEW YORK, NEW YORKKohlberg Kravis Roberts & Co.NEW YORKKohlberg Kravis Roberts & Co.NEW YORKHENRY R  KRAVISNEW YORKHENRY R  KRAVIS NEW YORKMARC S  LIPSCHULTZNEW YORKIain  McGillSVP, Europe & Rest of World DUBLIN 4Heather Ann  McSharryDirector DUBLIN 4Michaelson  MichaelMenlo ParkMichelson  MichaelMenlo ParkMICHAEL W  MICHELSONDirector MENLO PARKMICHAEL W  MICHELSONDirector MENLO PARKMICHAEL W  MICHELSONDirector MENLO PARKROBERTO  MIGNONENEW YORKROBERTO  MIGNONENEW YORKROBERTO  MIGNONENEW YORKMICHAEL PATRICK  MILLEREVP, US Commercial PALO ALTOMICHAEL PATRICK  MILLERDUBLIN 4JAMES C  MOMTAZEEDirector MENLO PARKJAMES C  MOMTAZEEDirector MENLO PARKJAMES C  MOMTAZEENEW YORKSeamus  MulliganDirector DUBLIN 2Seamus  MulliganDirector DUBLIN 4ROBERT M  MYERSPresident PALO ALTOROBERT M  MYERSPresident PALO ALTOM Zilkha  NathanielDirector MENLO PARKM Zilkha  NathanielMENLO PARKZilkha  NathanielMenlo ParkALEXANDAR  NAVAB JRNEW YORKSCOTT C  NUTTALLMENLO PARKSCOTT C  NUTTALLNEW YORKKenneth W  O'KeefeDirector CHICAGOKenneth W  O'KeefeDirector CHICAGOKenneth W  O'KeefeDirector CHICAGOEnright  PatrickMenlo ParkPAUL E  RAETHER NEW YORKNORBERT G  RIEDELDirector DEERFIELDNORBERT G  RIEDELDirector DUBLIN 4Myers  RobertPalo AltoGEORGE R  ROBERTSNEW YORKGEORGE R  ROBERTSMENLO PARKGEORGE R  ROBERTSNEW YORKSamuel R  SaksChief Executive Officer PALO ALTOSamuel R  SaksChief Executive Officer PALO ALTOColella  SamuelMenlo ParkElmar  SchneeDirector DUBLIN 4ALAN  SEBULSKYDirector PALO ALTOALAN  SEBULSKYDirector DUBLIN 2Karen L.  SmithEVP, R&D and CMO DUBLIN 4Catherine A.  SohnDirector DUBLIN 2Catherine A.  SohnDirector DUBLIN 4SWIFTCURRENT OFFSHORE LTDNEW YORKSWIFTCURRENT OFFSHORE LTDNEW YORKPARTNERS  SWIFTCURRENTNEW YORKPARTNERS  SWIFTCURRENTNEW YORKJAMES B  TANANBAUMDirector PALO ALTOJAMES B  TANANBAUMDirector PALO ALTOJAMES B  TANANBAUMDirector PALO ALTOJAMES B  TANANBAUMDirector SAN FRANCISCOTHOMA CRESSEY EQUITY PARTNERS INC10% Owner CHICAGOThoma Cressey Friends Fund VII, L.P.CHICAGOTHOMA CRESSEY FUND VII LPCHICAGOJeffrey K  TobiasEVP, R&D & CMO SAN CARLOSJeffrey K  TobiasPALO ALTOJeffrey K  TobiasDUBLIN 2Jeffrey K  TobiasEVP, Research & Dev and CMO DUBLIN 4Jeffrey K  TobiasEVP, R&D & CMO DUBLIN4Paul  TreacySVP, Technical Operations DUBLIN 4KAREN J  WILSONSVP, Finance & PAO SOUTH SAN FRANCISCOKAREN J  WILSONVP, Finance & PAO PALO ALTOKAREN J  WILSONVP, Finance & PAO DUBLIN 2KAREN J  WILSONSVP, Finance & PAO DUBLIN 4Rick E  WinninghamDirector SOUTH SAN FRANCISCORick E  WinninghamDirector SOUTH SAN FRANCISCORick E  WinninghamDirector SOUTH SAN FRANCISCOJanne LT  WisselSVP, Chief Regulatory Officer PALO ALTOMatthew P.  YoungEVP & CFO DUBLIN 4Nathaniel M  ZilkhaDirector MENLO PARKNathaniel M  ZilkhaDirector MENLO PARKPersons related to JAMES B  TANANBAUM - HANSEN MEDICAL INCNamePositionCityHsieh, J.D., Ph.D.  ArthurMountain ViewBRUCE  BARCLAYDirector MOUNTAIN VIEWALEXANDER E  BARKASPALO ALTOALEXANDER E  BARKASPALO ALTOALEXANDER E  BARKASPALO ALTOMARJORIE L.  BOWENDirector DALLASMARJORIE L.  BOWENDirector MANHATTAN BEACHMARJORIE L.  BOWENDirector MOUNTAIN VIEWSheahan  BrianMountain ViewBarclay  BruceMountain ViewCarolyn M  BrugueraVP, General Counsel MOUNTAIN VIEWBruguera  CarolynMountain ViewVance  CaryMountain ViewRobert O  CathcartSVP, Global Sales MONTVALE, NJRobert O  CathcartSVP, Global Sales MOUNTAIN VIEWJean  ChangVice President of Engineering MOUNTAIN VIEWLowe  ChristopherMountain ViewLowe  ChristopherMountain ViewMICHAEL L  EAGLEDirector SAN DIEGO, CAMICHAEL L  EAGLEDirector MOUNTAIN VIEWMICHAEL L  EAGLEDirector MOUNTAIN VIEWLARRY N  FEINBERG10% Owner GREENWICHLARRY N  FEINBERG10% Owner GREENWICHLARRY N  FEINBERG10% Owner GREENWICHLARRY N  FEINBERG10% Owner GREENWICHSchembri, Jr.  FrankMountain ViewMoll, M.D.  FredericMountain ViewJohn Gordon  FreundDirector PALO ALTOJoseph James  GuidoVP, Marketing & Business Dev MOUNTAIN VIEWJoseph James  GuidoVP, Marketing & Business Dev MOUNTAIN VIEWRUSSELL C  HIRSCHDirector PALO ALTORUSSELL C  HIRSCHPALO ALTORUSSELL C  HIRSCHDirector PALO ALTOArthur S.  HsiehVice President, Legal Affairs MOUNTAIN VIEWKenneth T.  HustedMOUNTAIN VIEWKevin  HykesDirector MOUNTAIN VIEWSchuler  JackMountain ViewSchuler  JackMountain ViewJack W. Schuler Living TrustLAKE FORESTRita V.  JacobVP Training & Clinical Affairs MOUNTAIN VIEWRita V.  JacobVP Training & Clinical Affairs MOUNTAIN VIEWShapiro  JamesMountain ViewChang  JeanMountain ViewGuido  JosephMountain ViewGuido  JosephMountain ViewMandato  JosephMountain ViewYASUNORI  KANEKOPALO ALTOYASUNORI  KANEKOPALO ALTOHykes  KevinMountain ViewHykes  KevinMountain ViewSusan  LeonardVice President, Human Resource MOUNTAIN VIEWCHRISTOPHER P.  LOWEInterim CFO MOUNTAIN VIEWCHRISTOPHER P.  LOWEInterim CFO MOUNTAIN VIEWMichael T.  MacKinnonVP U.S. Commercial Operations MOUNTAIN VIEWJoseph M  MandatoDirector MENLO PARKJoseph M  MandatoDirector PALO ALTOJoseph M  MandatoDirector MENLO PARKPETER J  MARIANIChief Financial Officer MOUNTAIN VIEWPETER J  MARIANIChief Financial Officer MOUNTAIN VIEWBowen  MarjorieMountain ViewBowen  MarjorieMountain ViewThomas M  McConnellDirector PALO ALTOThomas M  McConnellDirector PALO ALTOEagle  MichaelMountain ViewEagle  MichaelMountain ViewMacKinnon  MichaelMountain ViewRobert  MittendorffVP Marketing & Bus Dev MOUNTAIN VIEWFREDERIC H  MOLLChief Executive Officer MOUNTAIN VIEWFREDERIC H  MOLLDirector MOUNTAIN VIEWM Sean  MurphySr VP Operations MOUNTAIN VIEWYared  NadimMountain ViewYared  NadimMountain ViewStephen L  NewmanDirector DALLASStephen L  NewmanDirector MOUNTAIN VIEWOracle Associates LLCGREENWICHOracle Associates LLCGREENWICHORACLE INSTITUTIONAL PARTNERS L PGREENWICHORACLE PARTNERS LPGREENWICHORACLE PARTNERS LPGREENWICHOracle Ten Fund Master, LPGREENWICHPeter  OsborneInterim CFO MOUNTAIN VIEWRoland  PeplinskiGM EMEA & Asia Pacific MOUNTAIN VIEWMariani  PeterMountain ViewPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT VENTURE PARTNERS II LP10% Owner PALO ALTOPROSPECT VENTURE PARTNERS II LP10% Owner PALO ALTOGARY C  RESTANIPresident and COO MOUNTAIN VIEWGARY C  RESTANIDirector MOUNTAIN VIEWJacob  RitaMountain ViewJacob  RitaMountain ViewCathcart  RobertMountain ViewCathcart  RobertMountain ViewMittendorff, M.D.  RobertMountain ViewWILLIAM R  ROHNDirector CONCORDWILLIAM R  ROHNDirector MOUNTAIN VIEWPeplinski  RolandMountain ViewPeplinski, Ph.D.  RolandMountain ViewHirsch  RussellMountain ViewHirsch, M.D., Ph.D.  RussellMountain ViewFrank M. Jr.  SchembriVice President Manufacturing MOUNTAIN VIEWFrank M. Jr.  SchembriVice President Manufacturing MOUNTAIN VIEWDAVID  SCHNELLPALO ALTODAVID  SCHNELLPALO ALTODAVID  SCHNELLPALO ALTOFamily Foundation  Schuler10% Owner LAKE FORESTFamily Foundation  SchulerLAKE FORESTJACK W  SCHULERDirector TUCSONJACK W  SCHULERDirector LAKE FORESTChristopher  SellsMOUNTAIN VIEWChristopher  SellsSr VP Commercial Operations MOUNTAIN VIEWJAMES M  SHAPIRODirector SAN FRANCISCOJAMES M  SHAPIRODirector SAN FRANCISCODAVID M  SHAWSr VP Bus Dev, General Counsel MOUNTAIN VIEWBrian  SheahanVP, Regulatory, Clinical & QA MOUNTAIN VIEWSkyline Expansion Fund, L.P.PALO ALTOSkyline Expansion Fund, L.P.PALO ALTOSkyline Expansion Fund Management, LLCPALO ALTOSkyline Venture Management III, LLCPALO ALTOSkyline Venture Partners III, L.P.10% Owner PALO ALTOSkyline Venture Partners Qualified Purchaser Fund III, L.P.Director PALO ALTONewman  StephenMountain ViewNewman  StephenMountain ViewLeonard  SusanMountain ViewLeonard  SusanMountain ViewWilliam Mitchell  SuttonChief Operating Officer MOUNTAIN VIEWJAMES B  TANANBAUMPALO ALTOJAMES B  TANANBAUMPALO ALTOJAMES B  TANANBAUMPALO ALTODICK STEVEN M  VANCFO, VP Finance and Admin MOUNTAIN VIEWDICK STEVEN M  VANCFO, VP Finance and Admin MOUNTAIN VIEWCary Guy  VancePresident and CEO MOUNTAIN VIEWDaniel T.  WallaceSVP & Chief Technology Officer MOUNTAIN VIEWWILL K  WEINSTEINDirector MOUNTAIN VIEWWILL K  WEINSTEINDirector SAN FRANCISCOWeinstein  WillMountain ViewWeinstein  WilliamMountain ViewRohn  WilliamMountain ViewRohn  WilliamMountain ViewSutton  WilliamMountain ViewSutton  WilliamMountain ViewNadim  YaredDirector MOUNTAIN VIEWROBERT G  YOUNGEMOUNTAIN VIEWPersons related to JAMES B  TANANBAUM - Trubion Pharmaceuticals, IncNamePositionCityABBOTT BIOTHERAPEUTICS CORP10% Owner REDWOOD CITYLABORATORIES  ABBOTT10% Owner ABBOTT PARKHove  AndersNew YorkARCH V ENTREPRENEURS FUND LPCHICAGOARCH VENTURE FUND V LP10% Owner CHICAGOARCH VENTURE PARTNERS V LLCCHICAGOARCH VENTURE PARTNERS V LPCHICAGOARCH VENTURE PARTNERS V LPCHICAGOALEXANDER E  BARKASPALO ALTOALEXANDER E  BARKASPALO ALTOJEFFREY T  BARNESBOSTONJohn  BencichV.P. and CFO SEATTLELee R  BrettmanDirector SUDBURYDaniel J  BurgeSEATTLEMICHELLE  BURRISSenior V.P. and C.O.O. SAMMAMISHCLINTON  BYBEECHICAGOMARK  CARTHYBOSTONEDWARD A  CLARKSEATTLEKEITH  CRANDELLCHICAGOMann  DavidSeattleSchnell  DavidPalo AltoFACET BIOTECH CORPREDWOOD CITYFHM III, LLC10% Owner SEATTLEFHM III, LLCSEATTLEFHM IV LLCSEATTLEFHM IV LPSEATTLEJONATHAN  FLEMINGBOSTONFrazier Affiliates III, LPSEATTLEFRAZIER AFFILIATES IV LPFRAZIER AFFILIATES IV LPSEATTLEFrazier Healthcare III, LPSEATTLEFRAZIER HEALTHCARE IV LPFRAZIER HEALTHCARE IV LPSEATTLESTEVEN  GILLISSEATTLESTEVEN  GILLISDirector SEATTLESTEVEN  GILLISEx. Chair. & President SEATTLEMARTHA  HAYDEN-LEDBETTERSHORELINEHEALTHCARE FOCUS FUND LPCHICAGOPatrick  HeronDirector SEATTLEPatrick J  HeronDirector PALO ALTOPatrick J  HeronDirector PAO ALTOPatrick J  HeronDirector MENLO PARKRUSSELL C  HIRSCHPALO ALTORUSSELL C  HIRSCHPALO ALTOAnders D  HoveDirector NEW YORKAnders D  HoveDirector NEW YORKDeeley  KathleenSeattleMohler  KendallSeattleSTEVEN  LAZARUSCHICAGOJeffrey A  Ledbetter10% Owner SHORELINEBrettman  LeeSudburyMICHAEL  LYTTONBOSTONDavid A  MannSEATTLEDavid A  MannDirector SEATTLEDavid A  MannDirector SEATTLEDavid A  MannDirector SEATTLEKATHLEEN  MCKEREGHANSVP and General Counsel SEATTLEBurris  MichelleSeattleKendall  MohlerSVP & Chief Scientific Officer SEATTLEMRNA FUND  II LPBOSTONROBERT  NELSENCHICAGOOBP MANAGEMENT IV LPBOSTONOXFORD BIOSCIENCE PARTNERS IV LP10% Owner BOSTONHeron  PatrickPalo AltoThompson  PeterSeattlePROSPECT ASSOCIATES II L PPALO ALTOPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT VENTURE PARTNERS II LP10% Owner PALO ALTOPROSPECT VENTURE PARTNERS II LPPALO ALTOSamuel R  SaksPALO ALTOSamuel R  SaksDirector PALO ALTOSamuel R  SaksDirector BURLINGAMESaks  SamuelSeattleDAVID  SCHNELLDirector PALO ALTODAVID  SCHNELLDirector PALO ALTODAVID  SCHNELLDirector PALO ALTOStromatt  ScottSeattleGillis  StevenSeattleSCOTT  STROMATTSVP and Chief Medical Officer SEATTLEJAMES B  TANANBAUMPALO ALTOJAMES B  TANANBAUMPALO ALTOPeter A  ThompsonPresident and CEO BELLEVUEVEF Management IV, LLC10% Owner NEW YORKVenrock Associates IV, L.P.10% Owner NEW YORKVenrock Entrepreneurs Fund IV, L.P.10% Owner NEW YORKVenrock Management IV, LLC10% Owner NEW YORKVenrock Partners, L.P.10% Owner NEW YORKVenrock Partners Management, LLC10% Owner NEW YORKALAN G  WALTONBOSTONPersons related to JAMES B  TANANBAUM - Vanda Pharmaceuticals Inc.NamePositionCityALEXANDER E  BARKASPALO ALTOPaolo  BaroldiSVP & Chief Medical Officer ROCKVILLEPaolo  BaroldiSVP & Chief Medical Officer WASHINGTONKENNETH  BATEDirector CAMBRIDGE,Bio One Capital Pte Ltd.SINGAPOREBio One Capital Pte Ltd.CENTROSBiomedical Sciences Investment Fund Pte Ltd.10% Owner SINGAPOREBiomedical Sciences Investment Fund Pte Ltd.10% Owner CENTROSGunther  BirznieksWASHINGTONJAMES C  BLAIR10% Owner PRINCETONCARE CAPITAL  II  LLC10% Owner PRINCETONCARE CAPITAL  II  LLC10% Owner PRINCETONCARE CAPITAL INVESTMENTS II LPPRINCETONCARE CAPITAL INVESTMENTS II LPPRINCETONCare Capital Offshore Investments II LPPRINCETONCare Capital Offshore Investments II LPPRINCETONWilliam D  ClarkROCKVILLEWilliam D  ClarkSr. VP, Chief Business Officer ROCKVILLEMICHAEL F  COLADirector WAYNEMICHAEL F  COLADirector WASHINGTONThomas Lyle  CopmannROCKVILLEDEERFIELD CAPITAL LP ET ALNEW YORKDeerfield International Master Fund, L.P.NEW YORKDeerfield International Master Fund, L.P.NEW YORKMANAGEMENT CO  DEERFIELDNEW YORKMANAGEMENT CO /NY  DEERFIELDDeerfield Mgmt L.P.NEW YORKDEERFIELD PARTNERS, LPNEW YORKDEERFIELD PARTNERS, LPNEW YORKDeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations International Master Fund, L.P.NEW YORKDomain Partners VI, L.P.10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONDP VI Associates, L.P.10% Owner PRINCETONRICHARD W  DUGANDirector GERMANTOWNRICHARD W  DUGANDirector SCOTTSDALERICHARD W  DUGANDirector GIBSONIA, PA 15044EDB Investments Pte Ltd.SINGAPOREEDB Investments Pte Ltd.CENTROSJohn Joseph  FeeneySVP & Chief Medical Officer ROCKVILLEJohn Joseph  FeeneyWASHINGTONJames E  Flynn10% Owner NEW YORKJames E  Flynn10% Owner NEW YORKSteven K  GalsonDirector ROCKVILLESteven K  GalsonDirector WASHINGTONAlbert W.  GianchettiSr.VP,Chief Commercial Officer ROCKVILLEThomas Edward  GibbsSVP, Chief Commercial Officer WASHINGTONRichard L.  GulinoSVP, General Counsel & Sec. WASHINGTONBrian K  HalakDirector PRINCETONRUSSELL C  HIRSCHPALO ALTOWAYNE T  HOCKMEYERDirector GAITHERSBURGStephanie Rast  IrishActing CFO/Treasurer ROCKVILLEHABIB  KAIROUZNEW YORKHABIB  KAIROUZNEW YORKARGERIS N  KARABELASDirector PRINCETONJames Patrick  KellyEVP & Chief Financial Officer ROCKVILLEJames Patrick  KellySVP, CFO, Sec & Treasurer WASHINGTONJAN  LESCHLYPRINCETONJAN  LESCHLYPRINCETONMARK  LESCHLYNEW YORKMARK  LESCHLYNEW YORKMEDIMMUNE INC /DE10% Owner GAITHERSBURGVINCENT  MILANODirector VINCENT  MILANODirector EXTONVINCENT  MILANODirector WASHINGTONROBERT J  MORE10% Owner PRINCETONDeepak Shripad  PhadkeVice President Manufacturing ROCKVILLEHOWARD H  PIENDirector EMERYVILLEHOWARD H  PIENDirector ROCKVILLEMihael Hristos  PolymeropoulosPresident and CEO ROCKVILLEMihael Hristos  PolymeropoulosPresident and CEO WASHINGTONPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT MANAGEMENT CO II LLC10% Owner PALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT VENTURE PARTNERS II LPPALO ALTOPROSPECT VENTURE PARTNERS II LP10% Owner PALO ALTODavid Russ  RamsayDirector PRINCETONDavid Russ  RamsayDirector PRINCETONRobert  RepellaSVP & Chief Commercial Officer ROCKVILLERobert  RepellaSVP & Chief Commercial Officer WASHINGTONGian Piero  ReverberiSVP & Chief Commercial Officer WASHINGTONRHO CAPITAL PARTNERS INCNEW YORKRHO CAPITAL PARTNERS INCNEW YORKCAPITAL PARTNERS VERWALTUNGS GMBH  RHONEW YORKCAPITAL PARTNERS VERWALTUNGS GMBH  RHONEW YORKRHO MANAGEMENT TRUST INEW YORKRHO MANAGEMENT TRUST INEW YORKRHO MANAGEMENT VENTURES IV LLCNEW YORKRHO MANAGEMENT VENTURES IV LLCNEW YORKRHO VENTURES IV GMBH & CO BETEILIGUNGS KGNEW YORKRHO VENTURES IV GMBH & CO BETEILIGUNGS KGNEW YORKRHO VENTURES IV LP10% Owner NEW YORKRHO VENTURES IV LP10% Owner NEW YORKRHO VENTURES IV QP LPNEW YORKRHO VENTURES IV QP LPNEW YORKJOSHUA  RUCHNEW YORKJOSHUA  RUCHNEW YORKDAVID  SCHNELLPALO ALTOKATHLEEN K  SCHOEMAKER10% Owner PRINCETONSTEVEN A  SHALLCROSSSr. VP, CFO, Treasurer ROCKVILLESTEVEN A  SHALLCROSSSr. VP, CFO, Treasurer ROCKVILLEJAMES B  TANANBAUMDirector PALO ALTOJAMES B  TANANBAUMDirector PALO ALTOTANG CAPITAL MANAGEMENT LLCSAN DIEGOTANG CAPITAL MANAGEMENT LLCSAN DIEGOTANG CAPITAL PARTNERS LPSAN DIEGOKEVIN C  TANG10% Owner SAN DIEGOJESSE I  TREU10% Owner PRINCETONNICOLE  VITULLO10% Owner PRINCETONThomas  WatkinsDirector ROCKVILLEThomas  WatkinsDirector LAKE FOREST












 











James Tananbaum - Director at WaveTec Vision Systems, Inc.



























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology








            You have  
            
9 free profiles

              left this month   
			      

                Start Your Free Trial ➤
              








            Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there?
            

                View on RelSci Pro ➤
              




























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink





James Tananbaum
Director at WaveTec Vision Systems, Inc.



Overview
Relationships Paths
Boards & Committees 


James Tananbaum
Director at WaveTec Vision Systems, Inc.



 Overview



Board Seats



1





Number of Relationships



                This person is connected to 38 people.
              






 Relationships
              See Details




James B. Tananbaum

Founder at Foresite Capital Management LLC




Thomas Berryman

Manager at Soft Health Technologies LLC





Richard Lindstrom

Medical Director at Midwest Surgical Services, Inc.




Bryant Fong

Managing Director at Biomark Capital Management Co. LLC





Charles Warden

Managing Director of Earlier Funds at Versant Venture Management LLC




Joseph M. Mandato

Co-Professor, Medical Device Innovation at Stanford University





Thomas G. Frinzi

Senior Vice President at Abbott Medical Optics, Inc.




Anthony Lando

Chief Executive Officer at Sebacia, Inc.





Sean Ianchulev

President & Chief Executive Officer at Eyenoviabio, Inc.




Daniel S. Durrie

Founder at Durrie Vision Equipment LLC







See 28 more listings with RelSci Professional.

Start My Free Trial ➤








See 28 More 


 


 Paths to James Tananbaum



            James Tananbaum          




 You



 Connections via Relationship Science



 James Tananbaum






Sync your contacts to see how you can connect with James Tananbaum.

Start My Free Trial ➤








See  More 


 


 Boards & Committees



Corporate Boards ▾




Director

                    Tenure Unconfirmed                  


WaveTec Vision Systems, Inc.

                    WaveTec Vision Systems, Inc. develops and provides wavefront measurement technologies. It focuses on research, development, manufacturing, and distribution of the Optiwave Refractive Analysis (ORA) system with VerifEye used during cataract surgery. The firm offers ophthalmic medical devices. The company was founded by Kenneth C. Aldrich, William B. Adams, Thomas J. Berryman, and Tony Van Heugten in 1997 and is headquartered in Aliso Viejo, CA.                  





 Other Affiliations




              James Tananbaum is affiliated with
                            WaveTec Vision Systems, Inc..
            





You've reached your 10 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited article views and much more!

Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.












Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤















Cogentus Pharmaceuticals: James B. Tananbaum











 







 
 
 


 
 




 
 




 
 




 
 




 
 




 
 




 
 




 


 


 


 


 


 








 















 






















James 
                          B. Tananbaum, M.D.
                          Co-founder and Director
 James B. Tananbaum, M.D. is a Managing Director of 
                          Prospect Venture Partners. Dr. Tananbaum co-founded 
                          Prospect Venture Partners II and III, a dedicated life 
                          science fund with over $1 billion in capital under management. 
                        
During the last decade, he has helped found and lead 
                          financing for numerous biotechnology, pharmaceutical 
                          and healthcare service companies. 
Most recently, Dr. Tananbaum helped found and/or led 
                          investments for Prospect in Cogentus, Infinity Pharmaceuticals 
                          (NASDAQ: DPII), Jazz Pharmaceuticals, Novavax (NASDAQ:NVAX), 
                          Pathworks, RoxRo Pharma, Vanda Pharmaceuticals (NASDAQ: 
                          VNDA) and Vitae Pharmaceuticals. Previously, as a partner 
                          at Sierra Ventures he led investments in Amerigroup 
                          (NASDAQ:AMGP), Healtheon (NASDAQ:WBMD), Intensiva HealthCare 
                          Corporation (NASDAQ: CSEL) and NovaMed EyeCare Management 
                          (NASDAQ:NOVA). 
From 1991 to 1993, Dr. Tananbaum was a senior product 
                          manager at Merck & Company, Inc where he was part 
                          of the team responsible for repositioning Prilosec. 
                        
He was also the founder of two successful biotechnology 
                          companies: GelTex, which he founded in 1991 while finishing 
                          school and was ultimately purchased for $1.6 B by Genzyme 
                          (NASDAQ: GENZ); and Theravance (NASDAQ: THRX), founded 
                          in 1997 where as CEO for its first three years he started 
                          and grew the company to over 200 employees. 
Dr. Tananbaum is a member of the Young Presidents' 
                          Organization and Chapter Chair Golden Gate Chapter and 
                          a member of the Harvard/MIT Health Sciences and Technology 
                          Visiting Committee, and on the board of the DeYoung 
                          Museum of Fine Arts. 
He received his undergraduate degree and B.S.E.E. from 
                          Yale University, and MD and MBA from Harvard University.
< back



 
 
 











 
© 2007 Cogentus Pharmaceuticals. All 
                  rights reserved.



 









